Amundi’s NuVasive, Inc. NUVA Stock Holding History

Amundi’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,970	Closed	-$201K	–	1654
2021 Q2	$201K	Buy	+2,970	New	+$203K	﹤0.01%	1375

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Amundi's NUVA Position: Q3 2021 in Review

Amundi sold out of NuVasive, Inc. (NUVA) in Q3 2021, closing a stake of 2,970 shares — an estimated $201K sold.

Amundi first reported a position in NUVA in Q2 2021 and held it in 1 quarter. The position peaked at $201K in Q2 2021. 250 funds tracked by Wall St. Rank hold NUVA as of Q3 2021.

Amundi reported no remaining NuVasive, Inc. position as of Q3 2021 after selling out during the quarter.
Amundi sold 2,970 NuVasive, Inc. shares in Q3 2021, an estimated $201K.
Amundi first reported a position in NuVasive, Inc. in Q2 2021 and held it in 1 quarter.
Amundi's NuVasive, Inc. position peaked at $201K in Q2 2021.
250 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2021.

Based on Amundi's 13F filing for Q3 2021, filed 15 Nov 2021.